A 10-Week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) - Related Studies

A 10-Week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

This study is currently recruiting participants.

Study NCT00658008. Last updated on December 2, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Generalized Anxiety Disorder

2	Additional conditions recognized in this trial
		Anxiety Disorders
		Disease

3	More general conditions related to this trial
		Mental Disorders
		Pathologic Processes

4	Interventions listed in this trial
		PD 0332334
		Paroxetine
		Placebo

5	More general drug interventions related to this trial
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Central Nervous System Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses

6	Sponsors listed in this trial
		Pfizer